Monetary Management Group Inc. Has $218,000 Stock Position in Danaher Co. (NYSE:DHR)

Monetary Management Group Inc. lessened its holdings in Danaher Co. (NYSE:DHR) by 42.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 950 shares of the conglomerate’s stock after selling 700 shares during the quarter. Monetary Management Group Inc.’s holdings in Danaher were worth $218,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of DHR. Gilbert & Cook Inc. boosted its stake in Danaher by 2.5% in the fourth quarter. Gilbert & Cook Inc. now owns 1,749 shares of the conglomerate’s stock valued at $401,000 after acquiring an additional 42 shares during the last quarter. Grimes & Company Inc. boosted its position in shares of Danaher by 0.6% in the 4th quarter. Grimes & Company Inc. now owns 7,390 shares of the conglomerate’s stock worth $1,696,000 after purchasing an additional 43 shares during the last quarter. Dakota Community Bank & Trust NA boosted its position in shares of Danaher by 16.4% in the 4th quarter. Dakota Community Bank & Trust NA now owns 320 shares of the conglomerate’s stock worth $73,000 after purchasing an additional 45 shares during the last quarter. Howard Capital Management Group LLC grew its stake in shares of Danaher by 4.1% during the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock worth $342,000 after purchasing an additional 48 shares during the period. Finally, Spinnaker Trust increased its holdings in Danaher by 1.2% in the fourth quarter. Spinnaker Trust now owns 4,304 shares of the conglomerate’s stock valued at $988,000 after purchasing an additional 50 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Trading Down 5.9 %

Shares of NYSE:DHR opened at $180.64 on Friday. The stock has a market capitalization of $129.11 billion, a PE ratio of 34.21, a price-to-earnings-growth ratio of 2.66 and a beta of 0.86. The company’s 50-day moving average price is $204.24 and its two-hundred day moving average price is $230.46. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. Danaher Co. has a one year low of $171.00 and a one year high of $281.70.

Danaher (NYSE:DHR) last released its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter last year, the firm earned $2.09 EPS. On average, equities analysts forecast that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a $0.32 dividend. The ex-dividend date of this dividend is Friday, March 28th. This is a boost from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a dividend yield of 0.71%. Danaher’s dividend payout ratio (DPR) is currently 24.24%.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the company. Bank of America upgraded Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price on the stock in a report on Friday, December 13th. Wells Fargo & Company decreased their price objective on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a report on Thursday, January 30th. The Goldman Sachs Group upgraded shares of Danaher from a “neutral” rating to a “buy” rating and set a $260.00 target price on the stock in a report on Friday, March 21st. Royal Bank of Canada reissued an “outperform” rating and issued a $277.00 price target (down previously from $299.00) on shares of Danaher in a report on Thursday, January 30th. Finally, Raymond James reaffirmed a “market perform” rating on shares of Danaher in a research note on Monday, February 3rd. Four analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $276.57.

Insider Buying and Selling

In related news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 11.10% of the stock is owned by corporate insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.